List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=3
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 728,
    "next": "http://api.gregory-ms.com/trials/?page=4",
    "previous": "http://api.gregory-ms.com/trials/?page=2",
    "results": [
        {
            "trial_id": 375273,
            "title": "Effect of Acupuncture on Heart Rate Variability in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Other: Acupuncture Active;   Other: Acupuncture Sham<br /><b>Sponsor</b>:    University of Sao Paulo<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-31T12:00:00Z",
            "discovery_date": "2022-08-31T14:55:12.096764Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05523466?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 374738,
            "title": "Development, Reliability and Validity of the Telerehabilitation Satisfaction Questionnaire- TSQ",
            "summary": "<b>Condition</b>:    Neurological Disease<br /><b>Intervention</b>:    Other: Development of the Telerehabilitation Satisfaction Questionnaire<br /><b>Sponsor</b>:    Gazi University<br /><b>Active, not recruiting</b>",
            "published_date": "2022-08-30T12:00:00Z",
            "discovery_date": "2022-08-30T19:15:12.856445Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05520554?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 373795,
            "title": "Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis, Relapsing-remitting<br /><b>Intervention</b>:    Other: Peer support<br /><b>Sponsor</b>:    Nantes University Hospital<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-29T12:00:00Z",
            "discovery_date": "2022-08-29T12:20:12.112100Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05519553?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 370859,
            "title": "A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing (EID) of Natalizumab (BG00002) in Subjects With Rela...",
            "summary": "<p>EudraCT Number: 2018-002145-11<br />Sponsor Protocol Number: 101MS329<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2019-03-21<br />Medical condition: Relapsing-remitting multiple sclerosis (RRMS)<br />Disease: <br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002145-11/GB\">GB</a> (GB - no longer in EU/EEA), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002145-11/DE\">DE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002145-11/FR\">FR</a> (Ongoing), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002145-11/NL\">NL</a> (Ongoing), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002145-11/ES\">ES</a> (Ongoing), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002145-11/IT\">IT</a> (Ongoing)</p>",
            "published_date": null,
            "discovery_date": "2022-08-25T12:45:08.900676Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002145-11",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 370808,
            "title": "Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Behavioral: Guidelines for Exercise in Multiple Sclerosis (GEMS);   Behavioral: FLEX Stretching and Toning Program<br /><b>Sponsors</b>:    University of Illinois at Chicago;   University of Alabama at Birmingham;   Bristol-Myers Squibb Foundation<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-25T12:00:00Z",
            "discovery_date": "2022-08-25T11:05:08.383517Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05516537?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 370807,
            "title": "Pharmacogenetics of Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Genetic: Genetic polymorphism;   Diagnostic Test: Measurement of fingolimod and fingolimod-phosphate concentrations<br /><b>Sponsor</b>:    University Hospital, Caen<br /><b>Recruiting</b>",
            "published_date": "2022-08-25T12:00:00Z",
            "discovery_date": "2022-08-25T11:05:08.380598Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05516303?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 369103,
            "title": "An open-label, adaptive design study in patients with amyotrophic lateral sclerosis (ALS) to characterize safety, tolerability and brain microglia response, as measured by TSPO binding, following m...",
            "summary": "<p>EudraCT Number: 2019-000826-22<br />Sponsor Protocol Number: CBLZ945C12201<br />Sponsor Name: Novartis Pharma AG<br />Start Date: 2019-09-17<br />Medical condition: Amyotrophic lateral sclerosis (ALS)<br />Disease: <br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10002026<br />Term: Amyotrophic lateral sclerosis<br />Level: PT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000826-22/SE\">SE</a> (Restarted), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000826-22/FI\">FI</a> (Restarted)</p>",
            "published_date": null,
            "discovery_date": "2022-08-23T06:00:10.564226Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000826-22",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 368478,
            "title": "Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br /><b>Intervention</b>:    Other: Multiparametric assessment<br /><b>Sponsors</b>:    University Hospital of Mont-Godinne;   Saint-Luc University Hospital<br /><b>Recruiting</b>",
            "published_date": "2022-08-22T12:00:00Z",
            "discovery_date": "2022-08-22T12:55:10.890711Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05510817?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 368474,
            "title": "Who Benefits Most From Cognitive Rehabilitation for Multiple Sclerosis?",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Behavioral: Cognitive Rehabilitation<br /><b>Sponsors</b>:    University of Nottingham;   MS Society;   University of Lincoln<br /><b>Not yet recruiting</b>",
            "published_date": "2022-08-22T12:00:00Z",
            "discovery_date": "2022-08-22T12:55:10.884001Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05509426?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 364489,
            "title": "A Multinational, Multicenter, Randomized, Parallel Group, Open-Label Study to Assess Medication Satisfaction in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Treated with Subcutaneous...",
            "summary": "<p>EudraCT Number: 2015-000922-12<br />Sponsor Protocol Number: TV44400-CNS-40083<br />Sponsor Name: Teva Pharmaceutical Industries, Ltd<br />Start Date: 2016-01-04<br />Medical condition: Relapsing-Remitting Multiple Sclerosis (RRMS)<br />Disease: <br />Version: 18.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/BE\">BE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/AT\">AT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/DE\">DE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/IE\">IE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/PL\">PL</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/FI\">FI</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/ES\">ES</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/HR\">HR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/FR\">FR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000922-12/IT\">IT</a> (Completed)</p>",
            "published_date": null,
            "discovery_date": "2022-08-17T12:50:07.394575Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000922-12",
            "source": null,
            "relevant": null
        }
    ]
}